Publications scientifiques

Publications scientifiques relevant du ERN-RND des 5 dernières années.

Intramedullary hemangioblastomas
David P, Messerer M, Aghakhani N, Benoudiba F, Adam C, Richard S, Parker F.
Neurochirurgie. 2016 Feb 26.

Percutaneous treatment of subarachnoid-pleural fistula with Onyx.
Knafo S,Parker F, Herbrecht A, Court C, Saliou G.
J Neurosurg Spine. 2013 Apr ;18(4):378-81.

Post-traumatic syringomyelia : What should know the urologist ?
Caremel R, Hamel O, Gerardin E, Lenormand L,Parker F, Lefort M, Grise P, Perrouin-Verbe B.
Prog Urol. 2013 Jan ;23(1):8-14. doi : 10.1016/j.purol.2012.09.009. Epub 2012 Oct 15. Review.

Clinical, functional and structural determinants of central pain in syringomyelia.
Hatem SM, Attal N, Ducreux D, Gautron M,Parker F, Plaghki L, Bouhassira D.
Brain. 2010 Nov ;133(11):3409-22. doi : 10.1093/brain/awq244. Epub 2010 Sep 17.

Surgical treatment of posttraumatic syringomyelia.
Aghakhani N, Baussart B, David P, Lacroix C, Benoudiba F, Tadie M,Parker F.
Neurosurgery. 2010 Jun ;66(6):1120-7 ; discussion 1127.

Assessment of spinal somatosensory systems with diffusion tensor imaging in syringomyelia.
Hatem SM, Attal N, Ducreux D, Gautron M,Parker F, Plaghki L, Bouhassira D.
J Neurol Neurosurg Psychiatry. 2009 Dec ;80(12):1350-6. doi : 10.1136/jnnp.2008.

Sonographic Evaluation of Fetal Conus Medullaris and Filum Terminale.
Mottet N, Saada J, Jani J, Martin A, Riethmuller D,Zerah M, Benachi A.
Fetal Diagn Ther. 2016 Mar 2

Preliminary results from the French study on prenatal repair for fetal myelomeningoceles (the PRIUM study)
Friszer S, Dhombres F, Di Rocco F, Rigouzzo A, Garel C, Guilbaud L, Forin V, Moutard ML,Zerah M, Jouannic JM.
J Gynecol Obstet Biol Reprod (Paris). 2015 Nov 9.

Sacral dimple : What form of management is best ?
Zanello M,Zerah M, Di Rocco F.
Arch Pediatr. 2015 Dec ;22(12):1298-301.

Impact of spinal dysraphism on urinary and faecal prognosis in 25 cases of cloacal malformation.
Muller CO, Crétolle C, Blanc T, Alova I, Jais JP, Lortat-Jacob S, Aigrain Y, Zérah M, Sarnacki S.
J Pediatr Urol. 2014 Dec ;10(6):1199-205.

Limits of the surgically induced model of myelomeningocele in the fetal sheep.
Guilbaud L, Garabedian C, Di Rocco F, Fallet-Bianco C, Friszer S,Zerah M, Jouannic JM.
Childs Nerv Syst. 2014 Aug ;30(8):1425-9.

Craniovertebral junction anomalies in achondroplastic children.
Reina V, Baujat G, Fauroux B, Couloigner V, Boulanger E, Sainte-Rose C, Maroteaux P, Merrer ML, Cormier-Daire V, Legai-Mallet L,Zerah M, Di Rocco F.
Adv Tech Stand Neurosurg. 2014 ;40:295-312.

Spinal cord malformations.
Zerah M, Kulkarni AV.
Handb Clin Neurol. 2013 ;112:975-91. doi : 10.1016/B978-0-444-52910-7.00018-0. Review

Prenatal repair of myelomeningocele : State of the art
Garabedian C, Di Rocco F, Fallet-Bianco C,Zerah M, Jouannic JM.
J Gynecol Obstet Biol Reprod (Paris). 2013 May ;42(3):227-31. doi : 10.1016/j.jgyn.2012.10.015. Epub 2013 Mar 1. Review.

Surgical treatment of a 180° thoracolumbar fixed kyphosis in a young achondroplastic patient : a one-stage ’in situ’ combined fusion and spinal cord translocation.
Aurégan JC, Odent T,Zerah M, Padovani JP, Glorion C.
Eur Spine J. 2010 Nov ;19(11):1807-11.

Translational neuropathic pain research : A clinical perspective.
Bouhassira D,Attal N.
Neuroscience. 2016 Mar 17. pii : S0306-4522(16)00252-9.

Safety and efficacy of repeated injections of botulinum toxin A in peripheral neuropathic pain (BOTNEP) : a randomised, double-blind, placebo-controlled trial.
Attal N, de Andrade DC, Adam F, Ranoux D, Teixeira MJ, Galhardoni R, Raicher I, Üçeyler N, Sommer C, Bouhassira D.
Lancet Neurol. 2016 Feb 29.

An introduction to the PAIN® supplement on neuropathic pain.
Attal N, Finnerup NB.
Pain. 2016 Feb ;157 Suppl 1:S1.

Pharmacotherapy of neuropathic pain : time to rewrite the rulebook ?
Finnerup NB,Attal N.
Pain Manag. 2015 Dec 17

Neuropathic pain phenotyping by international consensus (NeuroPPIC) for genetic studies : a NeuPSIG systematic review, Delphi survey, and expert panel recommendations.
Van Hecke O, Kamerman PR,Attal N, Baron R, Bjornsdottir G, Bennett DL, Bennett MI, Bouhassira D, Diatchenko L, Freeman R, Freynhagen R, Haanpää M, Jensen TS, Raja SN, Rice AS, Seltzer Z, Thorgeirsson TE, Yarnitsky D, Smith BH.
Pain. 2015 Nov ;156(11):2337-53.

Pharmacotherapy of neuropathic pain : which drugs, which treatment algorithms ?
Attal N, Bouhassira D.
Pain. 2015 Apr ;156 Suppl 1:S104-14.

Pharmacotherapy for neuropathic pain in adults : a systematic review and meta-analysis.
Finnerup NB,Attal N, Haroutounian S, McNicol E, Baron R, Dworkin RH, Gilron I, Haanpää M, Hansson P, Jensen TS, Kamerman PR, Lund K, Moore A, Raja SN, Rice AS, Rowbotham M, Sena E, Siddall P, Smith BH, Wallace M.
Lancet Neurol. 2015 Feb ;14(2):162-73.

Adherence of French GPs to chronic neuropathic pain clinical guidelines : results of a cross-sectional, randomized, ’e’ case-vignette survey.
Martinez V,Attal N, Vanzo B, Vicaut E, Gautier JM, Bouhassira D, Lantéri-Minet M.
PLoS One. 2014 Apr 18 ;9(4):e93855.

Refractory Chronic Pain Screening Tool (RCPST) : a feasibility study to assess practicality and validity of identifying potential neurostimulation candidates.
Baron R, Backonja MM, Eldridge P, Levy R, Vissers K,Attal N, Buchser E, Cruccu G, De Andrés J, Hansson P, Jacobs M, Loeser JD, Prager JP, Stanton Hicks M, Regnault A, Van den Abeele C, Taylor RS.
Pain Med. 2014 Feb ;15(2):281-91.

Pharmacological treatment of neuropathic pain in primary care
Attal N.
Rev Prat. 2013 Jun ;63(6):795-802. Review. French. Erratum in : Rev Prat. 2015 Feb ;65(2):187.

Value of quantitative sensory testing in neurological and pain disorders : NeuPSIG consensus.
Backonja MM,Attal N, Baron R, Bouhassira D, Drangholt M, Dyck PJ, Edwards RR, Freeman R, Gracely R, Haanpaa MH, Hansson P, Hatem SM, Krumova EK, Jensen TS, Maier C, Mick G, Rice AS, Rolke R, Treede RD, Serra J, Toelle T, Tugnoli V, Walk D, Walalce MS, Ware M, Yarnitsky D, Ziegler D.
Pain. 2013 Sep ;154(9):1807-19. doi : 10.1016/j.pain.2013.05.047. Epub 2013 Jun 3. Erratum in : Pain. 2014 Jan ;155(1):205

Neuropathic pain : mechanisms, therapeutic approach, and interpretation of clinical trials.
Attal N.
Continuum (Minneap Minn). 2012 Feb ;18(1):161-75. doi : 10.1212/01.CON.0000411564.41709.2d. Review

Automated single-trial assessment of laser-evoked potentials as an objective functional diagnostic tool for the nociceptive system.
Hatem SM, Hu L, Ragé M, Gierasimowicz A, Plaghki L, Bouhassira D,Attal N, Iannetti GD, Mouraux A.
Clin Neurophysiol. 2012 Dec ;123(12):2437-45. doi : 10.1016/j.clinph.2012.05.007. Epub 2012 Jun 15.

Do clinicians adhere to treatment recommendations for neuropathic pain ?
Cruccu G,Attal N.
Pain. 2012 Apr ;153(4):740-1. doi : 10.1016/j.pain.2012.02.019. Epub 2012 Feb 28.

[Therapeutic advances in pharmaceutical treatment of neuropathic pain].->]
Attal N.
Rev Neurol (Paris). 2011 Dec ;167(12):930-7. doi : 10.1016/j.neurol.2011.06.003. Epub 2011 Nov 17. Review.

The specific disease burden of neuropathic pain : results of a French nationwide survey.
Attal N, Lanteri-Minet M, Laurent B, Fermanian J, Bouhassira D.
Pain. 2011 Dec ;152(12):2836-43. doi : 10.1016/j.pain.2011.09.014. Epub 2011 Oct 20.

Assessing symptom profiles in neuropathic pain clinical trials : can it improve outcome ?
Attal N, Bouhassira D, Baron R, Dostrovsky J, Dworkin RH, Finnerup N, Gourlay G, Haanpaa M, Raja S, Rice AS, Simpson D, Treede RD.
Eur J Pain. 2011 May ;15(5):441-3.

Diagnosis and assessment of neuropathic pain : the saga of clinical tools.
Bouhassira D,Attal N.
Pain. 2011 Mar ;152(3 Suppl):S74-83. doi : 10.1016/j.pain.2010.11.027. Epub 2010 Dec 23. Review.

Clinical, functional and structural determinants of central pain in syringomyelia.
Hatem SM,Attal N, Ducreux D, Gautron M, Parker F, Plaghki L, Bouhassira D.
Brain. 2010 Nov ;133(11):3409-22. doi : 10.1093/brain/awq244. Epub 2010 Sep 17

NeuPSIG guidelines on neuropathic pain assessment.
Haanpää M,Attal N, Backonja M, Baron R, Bennett M, Bouhassira D, Cruccu G, Hansson P, Haythornthwaite JA, Iannetti GD, Jensen TS, Kauppila T, Nurmikko TJ, Rice AS, Rowbotham M, Serra J, Sommer C, Smith BH, Treede RD.
Pain. 2011 Jan ;152(1):14-27.

Screening tools for neuropathic pain : are they adaptable in different languages and cultures ?
Attal N.
Pain Med. 2010 Jul ;11(7):985-6. doi :

Efficacy and safety of two administration modes of an intra-detrusor injection of 750 units dysport® (abobotulinumtoxinA) in patients suffering from refractory neurogenic detrusor overactivity (NDO) : A randomised placebo-controlled phase IIa study.
Denys P, Del Popolo G,AmarencoG, Karsenty G, Le Berre P, Padrazzi B, Picaut P ; Dysport Study Group.
Neurourol Urodyn. 2016 Jan 12.

Solifenacin is effective and well tolerated in patients with neurogenic detrusor overactivity : Results from the double-blind, randomized, active- and placebo-controlled SONIC urodynamic study.
AmarencoG, Sutory M, Zachoval R, Agarwal M, Del Popolo G, Tretter R, Compion G, De Ridder D.
Neurourol Urodyn. 2015 Dec 29

Definition of botulinum toxin failure in neurogenic detrusor overactivity : Preliminary results of the DETOX survey
Peyronnet B, Sanson S,AmarencoG, Castel-Lacanal E, Chartier-Kastler E, Charvier K, Damphousse M, Denys P, de Seze M, Egon G, Even A, Forin V, Karsenty G, Kerdraon J, le Normand L, Loche CM, Manunta A, Mouracade P, Phe V, Previnaire JG, Ruffion A, Saussine C, Schurch B, Game X ; Membres du GENULF (Groupe d’étude de neuro-urologie de langue française) et du comité de neuro-urologie de l’AFU (Association française d’urologie).
Prog Urol. 2015 Dec ;25(17):1219-24.

Patient-reported outcomes with the β3-adrenoceptor agonist mirabegron in a phase III trial in patients with overactive bladder.
Khullar V,AmarencoG, Angulo JC, Blauwet MB, Nazir J, Odeyemi IA, Hakimi Z.
Neurourol Urodyn. 2015 Aug 19.

Seniority of neurobladder and effectiveness of a first intradetrusor injection of botulinum toxin
Lacout M, Guinet-Lacoste A, Popoff M, Verollet D, Lebreton F,AmarencoG.
Prog Urol. 2015 Sep ;25(11):642-8

Noxious stimuli and neurogenic overactive bladder
Soler JM,AmarencoG.
Prog Urol. 2015 Jun ;25(8):455-60

Urinary disorders, behavioral and cognitive therapy and functional disorder.
Ann Phys Rehabil Med. 2014 Aug-Sep ;57(6-7):483-5. doi : 10.1016/ Epub 2014 Jun 5.

How to define refractory overactive bladder ?
AmarencoG, Deffieux X.
Prog Urol. 2014 Mar ;24(4):213-4. doi : 10.1016/j.purol.2014.01.004. Epub 2014 Feb 4.

Influence of a distraction task on pelvic floor muscle contraction.
Thubert T, Deffieux X, Jousse M, Guinet-Lacoste A, Ismael SS,AmarencoG.
Neurourol Urodyn. 2015 Feb ;34(2):139-43.

Therapeutic education and intermittent self-catheterization : recommendations for an educational program and a literature review.
Le Breton F, Guinet A, Verollet D, Jousse M,AmarencoG.
Ann Phys Rehabil Med. 2012 Apr ;55(3):201-12